The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Pharmaceutical Contract Sales Outsourcing (CSO), also known as Contract Sales Organization (CSO),means an Entity commonly and primarily known as a "contract sales organization" that is engaged primarily in the business of promoting products for third parties and is not, and is not a direct or indirect affiliate of, an entity commonly and primarily known as a "pharmaceutical", "biopharmaceutical" or "biotechnology" company; and (2) "Contract Sales Arrangement" shall mean an arrangement (that is terminable by the Company within three years without payment or penalty) between the Company and a Contract Sales Organization under which such Contract Sales Organization (A) would promote (and would only be granted such rights as are necessary to promote) a Company Pharmaceutical Product for a fee (which may be fixed or based upon a percentage of revenues or otherwise) but (B) would not be granted any research, development, manufacturing, sublicensing or other rights with respect to such Company Pharmaceutical Product or with respect to any Intellectual Property underlying or related to such Company Pharmaceutical Product except as necessary for the purpose of clause "(A)".
The Pharmaceutical Contract Sales Outsourcing (CSO) market covers Personal Promotion, Non-personal Promotion, Others, etc. The typical players include IQVIA, PHOENIX Group, Amplity Health, Ashfield Engage (Inizio), Syneos Health, EVERSANA, CMIC Group, EPS Corporation, etc.
The global Pharmaceutical Contract Sales Outsourcing (CSO) market was valued at US$ 7661.2 million in 2023 and is anticipated to reach US$ 12310 million by 2030, witnessing a CAGR of 7.1% during the forecast period 2024-2030.
Global key players of pharmaceutical contract sales outsourcing include China Medical System (CMS), IQVIA, PHOENIX Group, EVERSANA, etc. The top five players hold a share over 40%.
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Contract Sales Outsourcing (CSO), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Contract Sales Outsourcing (CSO).
Report Scope
The Pharmaceutical Contract Sales Outsourcing (CSO) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pharmaceutical Contract Sales Outsourcing (CSO) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmaceutical Contract Sales Outsourcing (CSO) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company (Partial List)
- China Medical System (CMS)
- IQVIA
- PHOENIX Group
- EVERSANA
- Ashfield Engage (Inizio)
- Amplity Health
- Sinco Pharma
- Syneos Health
- EPS Corporation
- Uniphar Group
- CMIC Group
- SciClone Pharmaceuticals
- China Pioneer Pharma
- Promoveo Health
- CSO Pharmitalia
- GTS Solution
- QFR Solutions
Segment by Type
- Personal Promotion
- Non-personal Promotion
- Others
Segment by Application
- Pharmaceutical Company
- Biotechnology Company
- Generic Company
- Others
By Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Russia)
- Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
- Latin America (Mexico, Brazil, Argentina)
- Middle East & Africa (Turkey, Saudi Arabia, UAE)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharmaceutical Contract Sales Outsourcing (CSO) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Personal Promotion
1.2.3 Non-personal Promotion
1.2.4 Others
1.3 Market by Application
1.3.1 Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical Company
1.3.3 Biotechnology Company
1.3.4 Generic Company
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Perspective (2019-2030)
2.2 Pharmaceutical Contract Sales Outsourcing (CSO) Growth Trends by Region
2.2.1 Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Pharmaceutical Contract Sales Outsourcing (CSO) Historic Market Size by Region (2019-2024)
2.2.3 Pharmaceutical Contract Sales Outsourcing (CSO) Forecasted Market Size by Region (2025-2030)
2.3 Pharmaceutical Contract Sales Outsourcing (CSO) Market Dynamics
2.3.1 Pharmaceutical Contract Sales Outsourcing (CSO) Industry Trends
2.3.2 Pharmaceutical Contract Sales Outsourcing (CSO) Market Drivers
2.3.3 Pharmaceutical Contract Sales Outsourcing (CSO) Market Challenges
2.3.4 Pharmaceutical Contract Sales Outsourcing (CSO) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmaceutical Contract Sales Outsourcing (CSO) Players by Revenue
3.1.1 Global Top Pharmaceutical Contract Sales Outsourcing (CSO) Players by Revenue (2019-2024)
3.1.2 Global Pharmaceutical Contract Sales Outsourcing (CSO) Revenue Market Share by Players (2019-2024)
3.2 Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pharmaceutical Contract Sales Outsourcing (CSO) Revenue
3.4 Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Concentration Ratio
3.4.1 Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical Contract Sales Outsourcing (CSO) Revenue in 2023
3.5 Pharmaceutical Contract Sales Outsourcing (CSO) Key Players Head office and Area Served
3.6 Key Players Pharmaceutical Contract Sales Outsourcing (CSO) Product Solution and Service
3.7 Date of Enter into Pharmaceutical Contract Sales Outsourcing (CSO) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmaceutical Contract Sales Outsourcing (CSO) Breakdown Data by Type
4.1 Global Pharmaceutical Contract Sales Outsourcing (CSO) Historic Market Size by Type (2019-2024)
4.2 Global Pharmaceutical Contract Sales Outsourcing (CSO) Forecasted Market Size by Type (2025-2030)
5 Pharmaceutical Contract Sales Outsourcing (CSO) Breakdown Data by Application
5.1 Global Pharmaceutical Contract Sales Outsourcing (CSO) Historic Market Size by Application (2019-2024)
5.2 Global Pharmaceutical Contract Sales Outsourcing (CSO) Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Pharmaceutical Contract Sales Outsourcing (CSO) Market Size (2019-2030)
6.2 North America Pharmaceutical Contract Sales Outsourcing (CSO) Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Country (2019-2024)
6.4 North America Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Size (2019-2030)
7.2 Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Country (2019-2024)
7.4 Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pharmaceutical Contract Sales Outsourcing (CSO) Market Size (2019-2030)
8.2 Asia-Pacific Pharmaceutical Contract Sales Outsourcing (CSO) Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Region (2019-2024)
8.4 Asia-Pacific Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pharmaceutical Contract Sales Outsourcing (CSO) Market Size (2019-2030)
9.2 Latin America Pharmaceutical Contract Sales Outsourcing (CSO) Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Country (2019-2024)
9.4 Latin America Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmaceutical Contract Sales Outsourcing (CSO) Market Size (2019-2030)
10.2 Middle East & Africa Pharmaceutical Contract Sales Outsourcing (CSO) Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Country (2019-2024)
10.4 Middle East & Africa Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 China Medical System (CMS)
11.1.1 China Medical System (CMS) Company Detail
11.1.2 China Medical System (CMS) Business Overview
11.1.3 China Medical System (CMS) Pharmaceutical Contract Sales Outsourcing (CSO) Introduction
11.1.4 China Medical System (CMS) Revenue in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2019-2024)
11.1.5 China Medical System (CMS) Recent Development
11.2 IQVIA
11.2.1 IQVIA Company Detail
11.2.2 IQVIA Business Overview
11.2.3 IQVIA Pharmaceutical Contract Sales Outsourcing (CSO) Introduction
11.2.4 IQVIA Revenue in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2019-2024)
11.2.5 IQVIA Recent Development
11.3 PHOENIX Group
11.3.1 PHOENIX Group Company Detail
11.3.2 PHOENIX Group Business Overview
11.3.3 PHOENIX Group Pharmaceutical Contract Sales Outsourcing (CSO) Introduction
11.3.4 PHOENIX Group Revenue in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2019-2024)
11.3.5 PHOENIX Group Recent Development
11.4 EVERSANA
11.4.1 EVERSANA Company Detail
11.4.2 EVERSANA Business Overview
11.4.3 EVERSANA Pharmaceutical Contract Sales Outsourcing (CSO) Introduction
11.4.4 EVERSANA Revenue in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2019-2024)
11.4.5 EVERSANA Recent Development
11.5 Ashfield Engage (Inizio)
11.5.1 Ashfield Engage (Inizio) Company Detail
11.5.2 Ashfield Engage (Inizio) Business Overview
11.5.3 Ashfield Engage (Inizio) Pharmaceutical Contract Sales Outsourcing (CSO) Introduction
11.5.4 Ashfield Engage (Inizio) Revenue in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2019-2024)
11.5.5 Ashfield Engage (Inizio) Recent Development
11.6 Amplity Health
11.6.1 Amplity Health Company Detail
11.6.2 Amplity Health Business Overview
11.6.3 Amplity Health Pharmaceutical Contract Sales Outsourcing (CSO) Introduction
11.6.4 Amplity Health Revenue in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2019-2024)
11.6.5 Amplity Health Recent Development
11.7 Sinco Pharma
11.7.1 Sinco Pharma Company Detail
11.7.2 Sinco Pharma Business Overview
11.7.3 Sinco Pharma Pharmaceutical Contract Sales Outsourcing (CSO) Introduction
11.7.4 Sinco Pharma Revenue in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2019-2024)
11.7.5 Sinco Pharma Recent Development
11.8 Syneos Health
11.8.1 Syneos Health Company Detail
11.8.2 Syneos Health Business Overview
11.8.3 Syneos Health Pharmaceutical Contract Sales Outsourcing (CSO) Introduction
11.8.4 Syneos Health Revenue in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2019-2024)
11.8.5 Syneos Health Recent Development
11.9 EPS Corporation
11.9.1 EPS Corporation Company Detail
11.9.2 EPS Corporation Business Overview
11.9.3 EPS Corporation Pharmaceutical Contract Sales Outsourcing (CSO) Introduction
11.9.4 EPS Corporation Revenue in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2019-2024)
11.9.5 EPS Corporation Recent Development
11.10 Uniphar Group
11.10.1 Uniphar Group Company Detail
11.10.2 Uniphar Group Business Overview
11.10.3 Uniphar Group Pharmaceutical Contract Sales Outsourcing (CSO) Introduction
11.10.4 Uniphar Group Revenue in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2019-2024)
11.10.5 Uniphar Group Recent Development
11.11 CMIC Group
11.11.1 CMIC Group Company Detail
11.11.2 CMIC Group Business Overview
11.11.3 CMIC Group Pharmaceutical Contract Sales Outsourcing (CSO) Introduction
11.11.4 CMIC Group Revenue in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2019-2024)
11.11.5 CMIC Group Recent Development
11.12 SciClone Pharmaceuticals
11.12.1 SciClone Pharmaceuticals Company Detail
11.12.2 SciClone Pharmaceuticals Business Overview
11.12.3 SciClone Pharmaceuticals Pharmaceutical Contract Sales Outsourcing (CSO) Introduction
11.12.4 SciClone Pharmaceuticals Revenue in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2019-2024)
11.12.5 SciClone Pharmaceuticals Recent Development
11.13 China Pioneer Pharma
11.13.1 China Pioneer Pharma Company Detail
11.13.2 China Pioneer Pharma Business Overview
11.13.3 China Pioneer Pharma Pharmaceutical Contract Sales Outsourcing (CSO) Introduction
11.13.4 China Pioneer Pharma Revenue in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2019-2024)
11.13.5 China Pioneer Pharma Recent Development
11.14 Promoveo Health
11.14.1 Promoveo Health Company Detail
11.14.2 Promoveo Health Business Overview
11.14.3 Promoveo Health Pharmaceutical Contract Sales Outsourcing (CSO) Introduction
11.14.4 Promoveo Health Revenue in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2019-2024)
11.14.5 Promoveo Health Recent Development
11.15 CSO Pharmitalia
11.15.1 CSO Pharmitalia Company Detail
11.15.2 CSO Pharmitalia Business Overview
11.15.3 CSO Pharmitalia Pharmaceutical Contract Sales Outsourcing (CSO) Introduction
11.15.4 CSO Pharmitalia Revenue in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2019-2024)
11.15.5 CSO Pharmitalia Recent Development
11.16 GTS Solution
11.16.1 GTS Solution Company Detail
11.16.2 GTS Solution Business Overview
11.16.3 GTS Solution Pharmaceutical Contract Sales Outsourcing (CSO) Introduction
11.16.4 GTS Solution Revenue in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2019-2024)
11.16.5 GTS Solution Recent Development
11.17 QFR Solutions
11.17.1 QFR Solutions Company Detail
11.17.2 QFR Solutions Business Overview
11.17.3 QFR Solutions Pharmaceutical Contract Sales Outsourcing (CSO) Introduction
11.17.4 QFR Solutions Revenue in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2019-2024)
11.17.5 QFR Solutions Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
